Heart failure (HF) exacerbations, characterized by pulmonary congestion and breathlessness, require frequent hospitalizations, often resulting in poor outcomes. Current methods for tracking lung fluid and respiratory distress are unable to produce continuous, holistic measures of cardiopulmonary health. We present a multimodal sensing system that captures bioimpedance spectroscopy (BIS), multi-channel lung sounds from four contact microphones, multi-frequency impedance pneumography (IP), temperature, and kinematics to track changes in cardiopulmonary status. We first validated the system on healthy subjects (n = 10) and then conducted a feasibility study on patients (n = 14) with HF in clinical settings. Three measurements were taken throughout the course of hospitalization, and parameters relevant to lung fluid status—the ratio of the resistances at 5 kHz to those at 150 kHz (K)—and respiratory timings (e.g., respiratory rate) were extracted. We found a statistically significant increase in K (p < 0.05) from admission to discharge and observed respiratory timings in physiologically plausible ranges. The IP-derived respiratory signals and lung sounds were sensitive enough to detect abnormal respiratory patterns (Cheyne–Stokes) and inspiratory crackles from patient recordings, respectively. We demonstrated that the proposed system is suitable for detecting changes in pulmonary fluid status and capturing high-quality respiratory signals and lung sounds in a clinical setting.

Objective: Evaluating convenient, wearable multi-frequency impedance pneumography (IP)-based respiratory monitoring in ambulatory persons with novel electrode positioning. Methods: A wearable multi-frequency IP system was utilized to estimate tidal volume (TV) and respiratory timings in 14 healthy subjects. A 5.1 cm × 5.1 cm tetrapolar electrode array, affixed to the sternum, and a conventional thoracic electrode configuration were employed to measure the respective IP signals, patch and thoracic IP. Data collected during static postures—sitting and supine—and activities—walking and stair-stepping—were evaluated against a simultaneously-obtained spirometer (SP) volume signal. Results: Across all measurements, estimated TV obtained from the patch and thoracic IP maintained a Pearson correlation coefficient ( r ) of 0.93 $ \pm $ 0.05 and 0.95 $ \pm $ 0.05 to the ground truth TV, respectively, with an associated root-mean-square error (RMSE) of 0.177 L and 0.129 L, respectively. Average respiration rates (RRs) were extracted from 30-second segments with mean-absolute-percentage errors (MAPEs) of 0.93% and 0.74% for patch and thoracic IP, respectively. Likewise, average inspiratory and expiratory timings were identified with MAPEs less than 6% and 4.5% for patch and thoracic IP, respectively. Conclusion: We demonstrated that patch IP performs comparably to traditional, cumbersome IP configurations. We also present for the first time, to the best of our knowledge, that IP can robustly estimate breath-by-breath TV and respiratory timings during ambulation. Significance: This work represents a notable step towards pervasive wearable ambulatory respiratory monitoring via the fusion of a compact chest-worn form factor and multi-frequency IP that can be readily adapted for holistic cardiopulmonary monitoring.

In neurodegenerative conditions like Parkinson’s disease (PD) and multiple system atrophy (MSA), cardiovascular autonomic dysfunction (CVAD) is associated with several poor longterm health outcomes. CVAD commonly manifests as orthostatic hypotension (OH), a sustained drop in blood pressure upon standing that can cause syncope and falls. Conventional screening methods for OH are suboptimal and formal autonomic testing is limited to specialized centers. This study explores a multimodal wearable sensing patch for remote monitoring of CVAD. We collected wave-form data during clinical autonomic testing and a 24-hour period at home from 20 participants with synucleinopathies (12 with OH) and 6 healthy controls. We developed an automated posture detection pipeline that identified 103 at-home orthostatic events. Then, physiomarkers related to heart rate variability, cardiac mechanics, and vasomotor function were derived during the supine and standing periods associated with clinical and at-home orthostatic transitions. Comparisons of baroreflex-related supine physiomarkers revealed significant differences between those with and without OH. We characterized cardiovascular autonomic dynamics while standing, leveraging low-dimensional representations, and found marked differences in the aggregate responses between groups. We also observed significantly higher within-subject similarity between the at-home responses of the OH group. Finally, we examined the discriminative power of the patch’s physiomarkers and demonstrated accurate classification of persons with OH during the clinical stand testing (F1=0.83). This study is the first to couple orthostatic event detection with machine learning analysis of wearable-derived physiomarkers, illustrating that wearable sensing can accurately classify OH and provide novel insights into CVAD outside the clinic.

Objective: Muscle health and decreased muscle performance (fatigue) quantification has proven to be an invaluable tool for both athletic performance assessment and injury prevention. However, existing methods estimating muscle fatigue are infeasible for everyday use. Wearable technologies are feasible for everyday use and can enable discovery of digital biomarkers of muscle fatigue. Unfortunately, the current state-of-the-art wearable systems for muscle fatigue tracking suffer from either low specificity or poor usability. Methods: We propose using dual-frequency bioimpedance analysis (DFBIA) to non-invasively assess intramuscular fluid dynamics and thereby muscle fatigue. A wearable DFBIA system was developed to measure leg muscle fatigue of 11 individuals during a 13-day protocol consisting of exercise and unsupervised at-home portions. Results: We derived a digital biomarker of muscle fatigue, fatigue score, from the DFBIA signals that was able to estimate the percent reduction in muscle force during exercise with repeated-measures Pearson's r = 0.90 and mean absolute error (MAE) of 3.6%. This fatigue score also estimated delayed onset muscle soreness with repeated-measures Pearson's r = 0.83 and MAE = 0.83. Using at-home data, DFBIA was strongly associated with absolute muscle force of participants (n = 198, p < 0.001). Conclusion: These results demonstrate the utility of wearable DFBIA for non-invasively estimating muscle force and pain through the changes in intramuscular fluid dynamics. Significance: The presented approach may inform development of future wearable systems for quantifying muscle health and provide a novel framework for athletic performance optimization and injury prevention.

Chronic respiratory diseases affect millions and are leading causes of death in the US and worldwide. Pulmonary auscultation provides clinicians with critical respiratory health information through the study of Lung Sounds (LS) and the context of the breathing-phase and chest location in which they are measured. Existing auscultation technologies, however, do not enable the simultaneous measurement of this context, thereby potentially limiting computerized LS analysis. In this work, LS and Impedance Pneumography (IP) measurements were obtained from 10 healthy volunteers while performing normal and forced expiratory (FE) breathing maneuvers using our wearable IP and respiratory sounds(WIRS) system. Simultaneous auscultation was performed with the Eko CORE stethoscope (EKO). The breathing phase context was extracted from the IP signals and used to compute phase-by-phase (Inspiratory (I), expiratory (E), and their ratio (I:E)) and breath-by-breath acoustic features. Their individual and added value was then elucidated through machine learning analysis. We found that the phase-contextualized features effectively captured the underlying acoustic differences between deep and FE breaths, yielding a maximum F1 Score of 84.1±11.4% with the phase-by-phase features as the strongest contributors to this performance. Further, the individual phase-contextualized models outperformed the traditional breath-by-breath models in all cases. The validity of the results was demonstrated for the LS obtained with WIRS, EKO, and their combination. These results suggest that incorporating breathing-phase context may enhance computerized LS analysis. Hence, multimodal sensing systems that enable this, such as WIRS, have the potential to advance LS clinical utility beyond traditional manual auscultation and improve patient care

Levodopa is the most common therapy to reduce motor symptoms of parkinsonism. However, levodopa has potential to exacerbate cardiovascular autonomic (CVA) dysfunction that may co-occur in patients. Heart rate variability (HRV) is the most common method for assessing CVA function, but broader monitoring of CVA function and levodopa effects is typically limited to clinical settings and symptom reporting, which fail to capture its holistic nature. In this study, we evaluated the feasibility of a multimodal wearable chest patch for monitoring changes in CVA function during clinical and 24-h ambulatory (at home) conditions in 14 patients: 11 with Parkinson’s disease (PD) and 3 with multiple system atrophy (MSA). In-clinic data were analyzed to examine the effects of orally administered levodopa on CVA function using a pre (OFF) and 60-min (ON) post-exposure protocol. Wearable-derived physiological markers related to the electrical and mechanical activity of the heart alongside vascular function were extracted. Pre-ejection period (PEP) and ratio of PEP to left ventricular ejection time index (LVETi) increased significantly (p<0.05) following levodopa, indicating a decrease in cardiac contractility. We further explored dose-response relationships and how CVA responses differed between participants with orthostatic hypotension (OH) from those without OH. Heart rate variability, specifically root-mean-square-of-successive-differences (RMSSD), following levodopa decreased significantly more in participants with OH (n = 7) compared to those without (no-OH, n = 7). The results suggest that the wearable patch’s measures are sensitive to CVA dynamics and provide exploratory insights into levodopa’s potential role in inducing a negative inotropic effect and exacerbating CVA dysfunction. This work encourages further evaluation of these wearable-derived physiomarkers for quantifying CVA and informing individualized care of individuals with parkinsonism.